Ovid Therapeutics Inc. (OVID) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 TAKEDA PHARMACEUTICAL CO LTD 5,750,000 주 보유. 기타 주요 보유자에는 LEVIN JEREMY M 및 Werber Yaron.
지난 12개월간 내부자는 19 건의 거래를 수행 OVID 주식 — 14 건 매수 (평가액 $6.15M) 및 2 건 매도 (평가액 $29.29K). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.
OVID 내부자 보유 현황
최대 보유자
TAKEDA PHARMACEUTICAL CO LTD
5,750,000 주
내부자 주요 보유자
| # |
이름 |
직책 |
보유 주식수 |
최종 신고일 |
상대적 규모 |
| 1 |
Takeda Pharmaceutical Co Ltd |
10 Percent Owner |
5,750,000 |
2019-11-22 |
|
| 2 |
Levin Jeremy M |
Director |
957,000 |
2026-03-02 |
|
| 3 |
Werber Yaron |
Cbo, CFO, Sec. and Treas. |
131,000 |
2018-01-23 |
|
| 4 |
Daly Timothy |
EVP,finance & Corp. Controller |
125,000 |
2020-12-21 |
|
| 5 |
Haasner Dirk |
SVP, Global Regulatory Affairs |
100,000 |
2020-12-21 |
|
| 6 |
Rakhit Amit |
President and CMO |
90,983 |
2021-07-16 |
|
| 7 |
Rona Jeffrey A |
Cbfo |
88,188 |
2026-03-02 |
|
| 8 |
During Matthew |
10 Percent Owner |
75,000 |
2019-04-03 |
|
| 9 |
Bernstein Karen |
Director |
65,000 |
2026-03-02 |
|
| 10 |
Papadopoulos Stelios |
Director |
65,000 |
2026-03-02 |
|
| 11 |
Friedman Bart |
Director |
65,000 |
2026-03-02 |
|
| 12 |
Duncan Barbara Gayle |
Director |
65,000 |
2026-03-02 |
|
| 13 |
Fitzgerald Kevin Joseph |
Director |
65,000 |
2026-03-02 |
|
| 14 |
Alexander Margaret A. |
President and CEO |
61,750 |
2026-03-02 |
|
| 15 |
Ward Ana |
SVP and General Counsel |
40,000 |
2019-02-26 |
|
| 16 |
Poole Robert Michael |
Director |
30,000 |
2024-02-26 |
|
| 17 |
Tardio Jason |
Chief Operating Officer |
28,125 |
2024-02-26 |
|
| 18 |
Perone Thomas Michael |
General Counsel, Secretary |
28,125 |
2024-02-26 |
|
| 19 |
Williams Douglas E |
Director |
1,750 |
2021-05-18 |
|
| 20 |
Takeda Pharmaceuticals U.s.a., Inc. |
Director |
1,250 |
2022-07-06 |
|
최근 거래 (최근 12개월)
| 날짜 |
이름 |
직책 |
유형 |
주식수 |
주가 |
금액 |
| 2026-03-23 |
Levin Jeremy M |
Executive Chairman |
옵션 행사 (매도) |
47,333 |
$1.40 |
$66.27K |
| 2026-02-26 |
Alexander Margaret A. |
President and CEO |
RSU 부여 |
1,435,000 |
$1.65 |
$2.37M |
| 2026-02-23 |
Alexander Margaret A. |
President and CEO |
정보 매도 |
11,656 |
$1.45 |
$16.9K |
| 2026-02-26 |
Fitzgerald Kevin Joseph |
Director |
RSU 부여 |
65,000 |
$1.65 |
$107.25K |
| 2026-02-26 |
Bernstein Karen |
Director |
RSU 부여 |
65,000 |
$1.65 |
$107.25K |
| 2026-02-26 |
Friedman Bart |
Director |
RSU 부여 |
65,000 |
$1.65 |
$107.25K |
| 2026-02-26 |
Duncan Barbara Gayle |
Director |
RSU 부여 |
65,000 |
$1.65 |
$107.25K |
| 2026-02-26 |
Rona Jeffrey A |
Cbfo |
RSU 부여 |
68,125 |
- |
- |
| 2026-02-23 |
Rona Jeffrey A |
Cbfo |
정보 매도 |
8,541 |
$1.45 |
$12.38K |
| 2026-02-26 |
Levin Jeremy M |
Director |
RSU 부여 |
957,000 |
$1.65 |
$1.58M |
| 2026-02-26 |
Papadopoulos Stelios |
Director |
RSU 부여 |
65,000 |
$1.65 |
$107.25K |
| 2026-01-04 |
Alexander Margaret A. |
President and CEO |
RSU 부여 |
890,000 |
$1.76 |
$1.57M |
| 2025-12-15 |
Levin Jeremy M |
CEO |
전환 (매도) |
71 |
- |
- |
| 2025-12-11 |
Levin Jeremy M |
CEO |
정보 매수 |
71 |
- |
- |
| 2025-12-08 |
Takeda Pharmaceutical Co Ltd |
10 Percent Owner |
전환 (매도) |
1,250 |
- |
- |
| 2025-02-20 |
Fitzgerald Kevin Joseph |
Director |
RSU 부여 |
45,000 |
$0.57 |
$25.65K |
| 2025-02-20 |
Bernstein Karen |
Director |
RSU 부여 |
45,000 |
$0.57 |
$25.65K |
| 2025-02-20 |
Friedman Bart |
Director |
RSU 부여 |
45,000 |
$0.57 |
$25.65K |
| 2025-02-20 |
Duncan Barbara Gayle |
Director |
RSU 부여 |
45,000 |
$0.57 |
$25.65K |
